Please login to the form below

Chugai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Chugai's Japan sales performance.

Chinese biotechs aim PD-L1 antibody at hepatitis B

Suzhou Alphamab is already testing its PD-L1 inhibitor antibody KN035 in a number of clinical trials across tumour types in the US, China and Japan, but has licensed rights for

Relearning launch: Four key dynamics for pharma launches in 2019

Japan is recalibrating its traditional national quantitative approach to care decisions with a new regional approach to qualitative health and quality-of-life targets.

Ashfield joins forces with Argon Global Healthcare Network

Doug Burcin, President, Ashfield Healthcare Communications. “We have a well-established presence in the UK, Germany, Japan and US for delivering our solutions at the intersection of science, data and creativity

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

inflammation test for managing asthma, across key markets such as the United States, China, and Japan, as well as the rest of the world.

Chugai gains FDA breakthrough status for rare CNS treatment

Adds to company's BTD roll-call. The FDA has granted Breakthrough Therapy Designation to Chugai’s satralizumab, a treatment currently in phase 3 for the rare CNS disorders neuromyelitis optica ... Satralizumab is a recycling antibody created via

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology